To access this element change to forms mode OFF
Grant Award View - GA293059
Pharmacogenomics for better treatment of fungal infections in cancer
GA ID:
GA293059
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2022
Publish Date:
30-Mar-2023
Category:
Medical Research
Grant Term:
29-Mar-2023 to 2-Sep-2026
Value (AUD):
$1,499,982.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Pharmacogenomics for better treatment of fungal infections in cancer
Purpose:
PRAGMATIC will deliver a high-quality and cost-effective approach to optimise the quality of care of cancer patients. This research will support pharmacists working to the full scope of practice, applying their expertise in using diagnostic and therapeutic innovations to provide patient-centred care.
We will achieve this by conducting a randomised clinical trial in cancer patients (aged =2 years) and prescribed voriconazole, in which we will compare the effectiveness of genomic-testing plus a genotype-based dosing guideline (ARM 1), with genomic-testing plus software-informed dose optimisation (ARM 2); coupled with an implementation project to ensure the future scalability of the interventions by tailoring them to each study setting.
GO ID:
GO Title:
MRFF 2022 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
Internal Reference ID:
MRFMMIP000040
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
THE UNIVERSITY OF QUEENSLAND
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
ST. LUCIA
Town/City:
ST. LUCIA
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
4029
Country:
AUSTRALIA